Sino Biopharmaceutical Limited
Status: Publicly traded
Direct answer
Sino Biopharmaceutical Limited is publicly traded on HKSE under the ticker 1177.HK.
Established in 2000 and headquartered in Wan Chai, Hong Kong, Sino Biopharmaceutical Limited functions as an investment holding entity overseeing a prominent research and development-focused pharmaceutical conglomerate. Its core operations are primarily situated within the People's Republic of China, segmented into three main areas: modern and traditional Chinese medicines and chemical pharmaceuticals, investment...
Can you invest in Sino Biopharmaceutical Limited?
Yes. Sino Biopharmaceutical Limited is publicly traded on HKSE under the ticker 1177.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sino Biopharmaceutical Limited
Detailed equity research is provided by MarketSnap.